Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer.
ESMO Open
; 2(3): e000219, 2017.
Article
en En
| MEDLINE
| ID: mdl-29209525
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Guideline
Idioma:
En
Revista:
ESMO Open
Año:
2017
Tipo del documento:
Article
País de afiliación:
Reino Unido